Veniti Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Veniti Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011372
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Veniti Inc (Veniti) is a medical device company that develops venous system management solutions. The company manufactures, develops, and markets medical devices for the treatment of chronic venous diseases. It provides VICI venous stent system that is used to treat venous outflow obstruction in the lower extremities. Veniti’s stent is designed to provide high crush resistance, end-to-end strength and shape with flexibility, and controlled deployment. The company caters to hospitals and clinics in the European Union. It operates in Saint Louis and Fremont. Veniti is headquartered in Fremont, California, the US.

Veniti Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Veniti Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Veniti Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Veniti Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Veniti Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Veniti Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Veniti Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Veniti Raises USD17 Million in Venture Financing 10
Veniti Raises US$9.7 Million In Venture Financing 11
Veniti Medical Raises US$15 Million In Venture Financing 12
Veniti Raises US$13.5 Million In Series A Venture Financing Round 13
Partnerships 14
Veniti Enters into Distribution Agreement with Boston Scientific 14
Equity Offering 15
VENITI Raises USD25 Million in Series D Equity Financing 15
Acquisition 16
Veniti Acquires Varix Medical And Teneo Medical 16
Veniti Inc – Key Competitors 17
Veniti Inc – Key Employees 18
Veniti Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Veniti Inc, Medical Equipment, Key Facts 2
Veniti Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Veniti Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Veniti Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Veniti Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Veniti Inc, Deals By Market, 2011 to YTD 2017 8
Veniti Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Veniti Raises USD17 Million in Venture Financing 10
Veniti Raises US$9.7 Million In Venture Financing 11
Veniti Medical Raises US$15 Million In Venture Financing 12
Veniti Raises US$13.5 Million In Series A Venture Financing Round 13
Veniti Enters into Distribution Agreement with Boston Scientific 14
VENITI Raises USD25 Million in Series D Equity Financing 15
Veniti Acquires Varix Medical And Teneo Medical 16
Veniti Inc, Key Competitors 17
Veniti Inc, Key Employees 18
Veniti Inc, Other Locations 19

★海外企業調査レポート[Veniti Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Asklepios BioPharmaceutical Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Asklepios Biopharmaceutical Inc (Asklepios Biopharmaceutical) is a drug development company that develops and markets novel protein and cellular based therapies. The company’s products include BNP-CHF, biostrophin, AskBio009, BNP-FVIII, BNP-RP, BNP-TLE, and BNP-OA. It also provides products …
  • Proteome Sciences Plc (PRM):製薬・医療:M&Aディール及び事業提携情報
    Summary Proteome Sciences Plc (Proteome Sciences) is a life sciences company that delivers content for personalized medicine through biomarkers, reagents and services. Its proteomics services include drug development, biomarker discovery and provision of data insights. It maps the protein expression …
  • Nephros Inc (NEPH):企業の財務・戦略的SWOT分析
    Summary Nephros Inc (Nephros) is dialysis device manufacturer. The company offers infection control filters, dialysis ultrafilters, and hemodia filtration systems. Its dialysis ultrafilters includes Endotoxin ten Cartridge filter, SSUmini, DSU-D and SSU-D. Nephros dialysis ultrafilters are intended …
  • Petroleum, Oil and Gas Corporation of South Africa (SOC) Ltd-石油・ガス分野:企業M&A・提携分析
    Summary Petroleum, Oil and Gas Corporation of South Africa (SOC) Ltd (PetroSA) a subsidiary of CEF SOC Limited, is an integrated oil and gas company. It explores and produces oil and natural gas resources. The company operates Jubilee, Oribi, and Oryx oil fields; F-A and F-A Satellite, E-M and E-M S …
  • Instituto Costarricense de Electricidad:電力:M&Aディール及び事業提携情報
    Summary Instituto Costarricense de Electricidad (ICE) is an autonomous institution of the Government of Costa Rica that provides electricity and telecommunications services. The company generates, transmits and distributes electricity; and constructs, operates, and maintains power plants. It uses cl …
  • Capstone Turbine Corporation (CPST):電力:M&Aディール及び事業提携情報
    Summary Capstone Turbine Corporation (CPST) is an energy company. It develops, manufactures, markets, and services microturbine technology solutions and power generation systems. The company integrates air bearing technology, advanced combustion technology, and power electronics to form efficient an …
  • Columbia Sportswear Company:企業の戦略・SWOT・財務情報
    Columbia Sportswear Company - Strategy, SWOT and Corporate Finance Report Summary Columbia Sportswear Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Inzpire Limited:企業の戦略・SWOT・財務情報
    Inzpire Limited - Strategy, SWOT and Corporate Finance Report Summary Inzpire Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Chembond Chemicals Ltd (530871):企業の財務・戦略的SWOT分析
    Chembond Chemicals Ltd (530871) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • China Cinda Asset Management Co Ltd:企業のM&A・事業提携・投資動向
    China Cinda Asset Management Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Cinda Asset Management Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on …
  • Anteo Diagnostics Ltd (ADO):企業の製品パイプライン分析2018
    Summary Anteo Diagnostics Ltd (Anteo Diagnostics) is a leading medical technology company that develops and commercializes healthcare products. The company along with its subsidiaries provides immunoassays, in-vitro diagnostics, and point of care (PoC) tests to life sciences, bio-separation, clinica …
  • Breeze-Eastern Corporation:企業の戦略・SWOT・財務情報
    Breeze-Eastern Corporation - Strategy, SWOT and Corporate Finance Report Summary Breeze-Eastern Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Halma Plc (HLMA):企業の財務・戦略的SWOT分析
    Halma Plc (HLMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Bioceptive Inc-医療機器分野:企業M&A・提携分析
    Summary Bioceptive Inc (Bioceptive) is a medical device company which provides women health solutions. The company offers products such as intrauterine devices, intuitive IUD insertion systems and IUD inserters, among others. Its intrauterine devices offer less traumatic cervical engagement and entr …
  • Whole Foods Market Inc:戦略・SWOT・企業財務分析
    Whole Foods Market Inc - Strategy, SWOT and Corporate Finance Report Summary Whole Foods Market Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • JMC Projects (India) Ltd (JMCPROJECT):企業の財務・戦略的SWOT分析
    JMC Projects (India) Ltd (JMCPROJECT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • ENCE Energia Y Celulosa SA (ENC):企業の財務・戦略的SWOT分析
    ENCE Energia Y Celulosa SA (ENC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Ogeda SA-製薬・医療分野:企業M&A・提携分析
    Summary Ogeda SA (Ogeda), formerly Euroscreen SA is a biotechnology company that develops small molecule drugs targeting G-protein coupled receptors. The company discovers and develops drugs that treats hormone-dependent pathologies in women's health. It also develops drugs to treat neurodegenerativ …
  • Invacare Corporation (IVC):医療機器:M&Aディール及び事業提携情報
    Summary Invacare Corporation (Invacare) is a medical equipment company which develops, manufactures and distributes healthcare products for non-acute care, such as the home healthcare and long term care markets. The major products include power wheelchairs, custom manual wheelchairs, personal mobili …
  • ESSA Pharma Inc (EPI)-製薬・医療分野:企業M&A・提携分析
    Summary Essa Pharma Inc (Essa Pharma) is a clinical-stage pharmaceutical company that carries out the development of small molecule drugs for the treatment castration-resistant prostate cancer (CRPC). The company’s lead product candidate, EPI-506, disrupts androgen receptor (AR) transcriptional acti …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆